“Scientists have identified components of the influenza virus that do not really change muchat all. The critical challenge is getting a vaccine to induce a response to those components.”
— Anthony Fauci, MD, Director, National Institute of Allergy and Infectious Diseases
An abundance of food and low activity levels have resulted in an increasing prevalence of metabolic syndrome that causes serious health risks.
New clinical studies show gene therapy may offer a cure for these chronic and expensive diseases in five to 10 years.
Why healthcare needs to pivot to meet the demands of an aging population.
Virtual clinical trials may increasingly replace in-person trials due to their advantages in helping to bring drugs to market.
While not all regulations and reimbursement models for telehealth post-COVID-19 are in place, some have become permanent and others may be extended.
Expansion of sites of care may soon provide more options for patients and caregivers.
The healthcare system is poised to change more in the next decade than it has in the past 50 years. At the root of this dynamic is an aging population and a pandemic that is transforming the way healthcare is delivered.
Will genetic testing and whole genome sequencing become part of the standard of care in treating patients?
Newly created treatments for high-risk COVID-19 patients have proved highly effective. Unfortunately, challenges with their distribution and administration have limited their use.
Much remains to be learned about this new condition affecting a growing number of children. However, it is hoped with increased vaccination and fewer cases of the SARS-CoV-2 virus, case numbers of MIS-C will also go down.
Discoveries about the types of immunity eventually led to the use of human antibodies to treat disease.
